| |
Latest 10 SEC filings (by transaction date) for VNDA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 5/24 | Williams Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -8,941 | $4.18 |
Mar 6/24 | Mar 5/24 | Wijkstrom Joakim | Direct Ownership | Common Stock | S - Open market or private sale | -9,229 | $4.21 |
Mar 6/24 | Mar 5/24 | Polymeropoulos Mihael Hristos | Direct Ownership | Common Stock | S - Open market or private sale | -24,288 | $4.13 |
Mar 6/24 | Mar 5/24 | Moran Kevin Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -8,902 | $4.20 |
Mar 6/24 | Mar 5/24 | Birznieks Gunther | Direct Ownership | Common Stock | S - Open market or private sale | -8,684 | $4.13 |
Mar 6/24 | Mar 4/24 | Williams Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -8,147 | $4.41 |
Mar 6/24 | Mar 4/24 | Wijkstrom Joakim | Direct Ownership | Common Stock | S - Open market or private sale | -7,498 | $4.41 |
Mar 6/24 | Mar 4/24 | Polymeropoulos Mihael Hristos | Direct Ownership | Common Stock | S - Open market or private sale | -30,884 | $4.24 |
Mar 6/24 | Mar 4/24 | Moran Kevin Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -5,798 | $4.48 |
Mar 6/24 | Mar 4/24 | Birznieks Gunther | Direct Ownership | Common Stock | S - Open market or private sale | -8,727 | $4.30 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for VNDA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 5/24 | Williams Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -8,941 | $4.18 |
Mar 6/24 | Mar 4/24 | Williams Timothy | Direct Ownership | Common Stock | S - Open market or private sale | -8,147 | $4.41 |
Mar 6/24 | Mar 5/24 | Wijkstrom Joakim | Direct Ownership | Common Stock | S - Open market or private sale | -9,229 | $4.21 |
Mar 6/24 | Mar 4/24 | Wijkstrom Joakim | Direct Ownership | Common Stock | S - Open market or private sale | -7,498 | $4.41 |
Mar 6/24 | Mar 5/24 | Polymeropoulos Mihael Hristos | Direct Ownership | Common Stock | S - Open market or private sale | -24,288 | $4.13 |
Mar 6/24 | Mar 4/24 | Polymeropoulos Mihael Hristos | Direct Ownership | Common Stock | S - Open market or private sale | -30,884 | $4.24 |
Mar 6/24 | Mar 5/24 | Moran Kevin Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -8,902 | $4.20 |
Mar 6/24 | Mar 4/24 | Moran Kevin Patrick | Direct Ownership | Common Stock | S - Open market or private sale | -5,798 | $4.48 |
Mar 6/24 | Mar 5/24 | Birznieks Gunther | Direct Ownership | Common Stock | S - Open market or private sale | -8,684 | $4.13 |
Mar 6/24 | Mar 4/24 | Birznieks Gunther | Direct Ownership | Common Stock | S - Open market or private sale | -8,727 | $4.30 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |